Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Angel Yeast Partners with PhaBuilder to Drive Wider Synthetic Biology Applications with Launch of Joint Venture PHA Factory 2023-06-29 20:00
HaemaLogiX Announces Positive Final Results from KappaMab Combination Phase IIb Myeloma Trial 2023-06-29 19:00
CPHI & PMEC China 2023 to launch international roadshow in Guangzhou 2023-06-29 18:10
Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore 2023-06-29 17:14
Clarity establishes a US Center of Excellence for Targeted Copper Theranostics 2023-06-28 20:58
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development 2023-06-28 20:00
LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma 2023-06-28 04:00
First Drug Discovered and Designed with Generative AI Enters Phase II Trials, with First Patients Dosed 2023-06-27 21:00
TMRW Life Sciences Names Louis Villalba Chief Executive Officer 2023-06-27 20:00
The Hong Kong Polytechnic University researchers develop Optoelectronic Graded Neurons for perceiving dynamic motion of Machine Vision Systems 2023-06-27 16:43
Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership 2023-06-27 15:33
Lion TCR Secures USD 40 million Series B2 Financing, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy 2023-06-27 08:30
New ZIRCON Phase III Data Presented at SNMMI: Potential Utility of TLX250-CDx in Staging and Monitoring ccRCC 2023-06-27 03:51
HitGen launches a newly upgraded version of OpenDEL™, a self-service screening kit, to facilitate innovative drug discovery research 2023-06-26 21:30
Angel Yeast Inks Agreements with Hubei Academy of Agricultural Sciences to Boost Agricultural Industrialization 2023-06-26 20:00
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening 2023-06-26 08:45
Ascletis Announces Poster Presentation of Phase II Study of ASC42 FXR Agonist for Functional Cure of Chronic Hepatitis B at EASL CONGRESS 2023 2023-06-26 08:10
Brii Biosciences Announces Entry into Definitive Agreements from Sale of its Equity Interest in Qpex Biopharma and Acquiring Exclusive Global Rights for BRII-693 2023-06-26 07:30
Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASL™ Congress 2023 2023-06-25 20:00
Sciwind Biosciences to Highlight Positive Clinical Data for GLP-1 Peptide Agonist Ecnoglutide (XW003) at the American Diabetes Association (ADA) 83rd Annual Conference 2023-06-24 10:00
1 96 97 98 99 100 452